oral HDV-Insulin (Oral HDV-I)
/ Diasome
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
May 14, 2021
A Single-Blind, Placebo-Controlled, Dose-Ranging Trial of Oral HDV-Insulin in Patients With Type 2 Diabetes Mellitus
(clinicaltrials.gov)
- P=N/A; N=6; Completed; Sponsor: Diasome Pharmaceuticals; N=20 ➔ 6
Clinical • Enrollment change • Diabetes • Metabolic Disorders • Type 1 Diabetes Mellitus • Type 2 Diabetes Mellitus
May 06, 2021
Study of Two Doses of Oral HDV-Insulin and Placebo With Background Metformin Treatment in Patients With Type 2 Diabetes Mellitus
(clinicaltrials.gov)
- P2/3; N=239; Completed; Sponsor: Diasome Pharmaceuticals; Active, not recruiting ➔ Completed
Clinical • Trial completion • Diabetes • Metabolic Disorders • Type 2 Diabetes Mellitus
1 to 2
Of
2
Go to page
1